1887

Abstract

SUMMARY

The varicella-zoster virus-infected cell proteins (VZV-ICPs) against which IgG, IgM and IgA antibodies were made in the course of primary varicella-zoster virus (VZV) infection were analysed by the immune transfer method. IgG antibodies were made against one or more of 18 VZV-ICPs by patients with varicella. IgM antibodies were produced which reacted with 21 VZV-ICPs. The spectrum of IgG antibody production during the first week after the onset of infection was limited to an average of three VZV-ICPs while IgM antibodies which reacted with an average of seven VZV-ICPs were detectable in the acute phase of varicella. Equivalent VZV IgG or IgM antibody titres by radioimmunoassay did not correlate with a similar pattern of antibody specificity for VZV-ICPs by immune transfer. A detectable immune response to all VZV-ICPs was not required for the recovery of individual patients from primary VZV infection.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-65-12-2141
1984-12-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/65/12/JV0650122141.html?itemId=/content/journal/jgv/10.1099/0022-1317-65-12-2141&mimeType=html&fmt=ahah

References

  1. Arvin A. M., Koropchak C. M. 1980; Immunoglobulins M and G to varicella-zoster virus measured by solid phase radioimmunoassay: antibody responses to varicella and herpes zoster infections. Journal of Clinical Microbiology 12:367–374
    [Google Scholar]
  2. Asano Y., Takahashi M. 1980; Studies on the polypeptides of varicella-zoster virus. II. Synthesis of viral polypeptides in infected cells. Biken Journal 23:95–106
    [Google Scholar]
  3. Braun D. K., Pereira L., Norrild B., Roizman B. 1983; Application of denatured, electrophoretically separated and immobilized lysates of herpes simplex virus infected cells for dectection of monoclonal antibodies and for studies of the properties of viral proteins. Journal of Virology 46:103–112
    [Google Scholar]
  4. Burnette N. 1981; ‘Western Blotting’: electrophoretic transfer of proteins from SDS-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Analytical Biochemistry 112:195–203
    [Google Scholar]
  5. Feldman S., Hughes W. T., Daniel C. B. 1975; Varicella in children with cancer. Pediatrics 56:388–397
    [Google Scholar]
  6. Grose C. 1983; Zoster in children with cancer: radioimmune precipitation profiles of sera before and after illness. Journal of Infectious Diseases 145:47–56
    [Google Scholar]
  7. Grose C., Friedrichs W. E. 1982; Immunoprecipitable polypeptides specified by varicella-zoster virus. Virology 118:86–95
    [Google Scholar]
  8. Grose C., Friedrichs W. E., Smith G. C. 1983; Purification and molecular anatomy of the varicella-zoster virion. Biken Journal 26:1–14
    [Google Scholar]
  9. Hyman R. W. 1983; Molecular biology of varicella-zoster virus. In The Herpesviruses p 120 Edited by Roizman B. New York & London: Plenum Press;
    [Google Scholar]
  10. Kallander C. F. R., Gronoivitz J. S., Torfason E. G. 1982; Human serum antibodies to varicella-zoster virus thymidine kinase. Infection and Immunity 36:30–37
    [Google Scholar]
  11. Lopetegui P., Matsunaga Y., Okuno T., Ogino T., Yamanishi K. 1983; Expression of varicella-zoster virus-related antigen in biochemically transformed cells. Journal of General Virology 64:1181–1186
    [Google Scholar]
  12. Preblud S. R., D’Angelo L. F. 1979; Chickenpox in the United States, 1972–1977. Journal of Infectious Diseases 140:257–260
    [Google Scholar]
  13. Shemer Y., Laventon-Kriss S., Sarov I. 1980; Isolation and polypeptide characterization of varicella-zoster virus. Virology 106:133–140
    [Google Scholar]
  14. Wolff M. H. 1978; The proteins of varicella-zoster virus. Medical Microbiology and Immunology 166:21–28
    [Google Scholar]
  15. Zweerink H. J., Neff B. J. 1981; Immune response after exposure to varicella-zoster virus: characterization of virus-specific antibodies and their corresponding antigens. Infection and Immunity 31:436–444
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-65-12-2141
Loading
/content/journal/jgv/10.1099/0022-1317-65-12-2141
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error